Researchers believe that they have developed a blood test that can detect autism spectrum disorder with 90% accuracy.
An Accurate Blood Test for Autism
An Accurate Blood Test for AutismResearchers believe that they have developed a blood test that can detect autism spectrum disorder with 90% accuracy.
Novartis Prepares to Sell Off U.S. Generic Pills Business
Novartis Prepares to Sell Off U.S. Generic Pills BusinessNovartis is gearing up to auction its U.S. generic pill business, a unit that has struggled amid fierce competition, a move pointing to the idea that biosimilars will be the end of 'big pharma'.
Global Standards to Increase Accuracy of BRCA Test Results is Needed
Global Standards to Increase Accuracy of BRCA Test Results is NeededThere are wide differences in BRCA testing protocols at labs around the world. A new article surveyed 86 laboratories about their BRCA testing practices and found that all the labs differed widely in their approach.
'Toolbox' Creates Custom Phages for Killing Pathogens
'Toolbox' Creates Custom Phages for Killing PathogensA new technology platform lets scientists systematically modify and customize bacteriophages, viruses that can attack and kill specific bacteria.
Could Altering Vaginal Bacteria Improve IVF Outcomes?
Could Altering Vaginal Bacteria Improve IVF Outcomes?Fertility clinics treat abnormal vaginal bacteria aiming to improve reproductive outcome.
Novartis is gearing up to auction its U.S. generic pill business, a unit that has struggled amid fierce competition, a move pointing to the idea that biosimilars will be the end of ‘big pharma’.
There are wide differences in BRCA testing protocols at labs around the world. A new article surveyed 86 laboratories about their BRCA testing practices and found that all the labs differed widely in their approach.
A new technology platform lets scientists systematically modify and customize bacteriophages, viruses that can attack and kill specific bacteria.
Fertility clinics treat abnormal vaginal bacteria aiming to improve reproductive outcome.
Using CRISPR on pigs to create organ regeneration isn’t a new idea, but George Church believes that pig-to-human organ transplant clinical trials could become a reality in just two years.
Festival of Genomics London 2018
In part one, we relived the excitement of January – June 2017. How did the year progress through the summer stretch and into the festive period? It’s only one way to find out…
Now that the Festival of Genomics London is done, dusted, and in the record books, we take a look back at what you were busy reading on our website during 2017, including your answers from our survey.
The Festival goes on, day two. We give you the highlights from some of the talks and discussions going down on our live blog.
The Short Read
“It’s Through Community Outreach & Education We Ensure Continued Public Commitment” – Hsiao-Tuan Chao
Hsiao-Tuan Chao is a physician-scientist in the field of child neurology, we’ve had a chat with her in this week’s Short Read.
“I’d Like to See Our Understanding of at Least One More Disease Transformed by Genomics and Big Data” – Jeremy Grushcow
Combining over 15 years’ experience with pharma and life sciences businesses with a passion for participant-centric research, Jeremy Grushcow is CBO at Sequence Bio, where he saw a once-in-in a lifetime opportunity to change how we treat, prevent and understand disease.
“The Disconnect Between the ‘Promise’ and the ‘Actual Impact’ is the Biggest Challenge in -Omics Based Technologies” – Zisis Kozlakidis
We’ve sat down with Dr Zisis Kozlakidis before his talk ‘Tracking Viruses in Space and Time’ at the Festival of Genomics in London 2018, were we talk virus.
Magazines and Educational Guides
We bring genomics to the UK in our latest issue, as we look ahead to what this year’s Festival of Genomics London has to offer.
In this issue of the magazine we tackle infectious disease, whilst taking a look at what AMP 2017 has on offer this year in Salt Lake City, Utah.
In this issue of the magazine we head to Orlando, Florida, for the largest genetics meeting in the world: welcome to ASHG 2017.
What’s blockchain technology, how, and why was it developed, and why is everyone talking about it? Alex Schmid provides us with an overview of challenges blockchain technology can help solve within life sciences, and what about it, that makes it so suitable.
Just as sequencing has been getting faster, so too has library preparation. The process can be broadly broken up into 5-6 main stages, depending on method.
Technology has come a long way in the last four decades. Dr. Tonellato has been able to watch how it has changed computational genomics for the better.
Learn more about Edico Genome’s new DRAGEN Virtual Long-Read Detection (VLRD) Pipeline, that’s the first variant caller dedicated to SDs, and is designed to run with short sequence reads generated at moderate coverage.
With do-it-yourself CRISPR kits now available online, Hannah Devlin asks if it’s really possible to edit your own DNA, is it safe and how should it be regulated?
A discussion of the technology that is in use today that allows Metabolon to carry out n of 1 studies that enable precision medicine, as well as future technology. Available on-demand.
Around the Web
QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing in second half 2018 in Europe and later in the U.S.
SeraCare announces industry’s first CNV-specific reference material for gene amplifications in breast, lung, and brain cancer.
NHGRI launches a new strategic plan to identify areas in genomics that will expand the field into new frontiers and enable novel applications to human health and disease.
Here are five stories you should read this week. The conversation with George Church is highly recommended!
Valentine’s Day is around the corner and whether we like it or not, scientists have done research on that too. Can science be applied to love?
Would you pay to give your child a genetic advantage, to make them smarter than their peers, taller, or more beautiful? This is a question that will become relevant within a few decades, according to Big Think — if not sooner.